Insmed
INSM
#652
Rank
S$46.17 B
Marketcap
S$216.50
Share price
-15.43%
Change (1 day)
117.26%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -S$1.45 Billion

According to Insmed's latest financial reports the company's current earnings are S$0.44 Billion. In 2024 the company made an earning of -S$1.08 Billion a decrease over its 2023 earnings that were of -S$0.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$1.45 Billion34.74%
2024 -S$1.08 Billion23.71%
2023 -S$0.87 Billion45.77%
2022 -S$0.6 Billion15.83%
2021 -S$0.52 Billion50.19%
2020 -S$0.35 Billion16.4%
2019 -S$0.3 Billion-23.9%
2018 -S$0.39 Billion59.35%
2017 -S$0.25 Billion8.52%
2016 -S$0.23 Billion47.25%
2015 -S$0.16 Billion34.53%
2014 -S$0.12 Billion58.83%
2013 -S$70.78 Million35.14%
2012 -S$52.38 Million-31.92%
2011 -S$76.94 Million854.92%
2010 -S$8.06 Million-105.22%
2009 S$0.15 B-905.06%
2008 -S$19.17 Million-27.31%
2007 -S$26.36 Million-62.41%
2006 -S$70.13 Million98.19%
2005 -S$35.38 Million0.03%
2004 -S$35.37 Million159.07%
2003 -S$13.66 Million-69.31%
2002 -S$44.49 Million
2000 -S$40.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-S$0.33 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.17 B-1,591.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
S$12.74 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S$5.68 M-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$29.98 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$5.75 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA